Artemisinin resistance reported in a second Cambodian province
12 November 2012
Researchers recently reported artemisinin-resistant Plasmodium falciparum in Pursat province, Cambodia. The international team, led by Rick Fairhurst of the US National Institutes of Health, detected slow parasite clearances rate when patients with falciparum malaria were treated with artesunate — a worrying sign that the parasite may be developing resistance to the frontline treatments for malaria. The findings provide important baseline information about parasite clearance to ongoing longitudinal studies which are monitoring the prevalence of artemisinin resistance and whether resistance is worsening. The study also considered the contribution of parasite genetics and host factors, finding two genetically distinct parasite clonal groups, along with evidence that host factors, such as erythrocyte polymorphisms, affect half-life.
The findings are published in Amaratunga C, Sreng S, Phelps ES, Stepniewska K, Lim P, et al. (2012) Artemisinin-resistant Plasmodium falciparum in Pursat Province, western Cambodia: a parasite clearance rate study. The Lancet Infectious Diseases, Volume 12, Issue 11, Pages 851 - 858, November 2012 doi:10.1016/S1473-3099(12)70181-0.
The article is freely available on the Malaria Nexus website for the coming three months: http://www.malarianexus.com/articles/artemisinin-resistant-plasmodium-falciparum-in-pursat-province/